UPDATE 1-U.S. COVID vaccine market could reach $13 bln -Moderna exec

(Adds more event details)

By Michael Erman

NEW YORK, Sept 8 (Reuters) – The annual U.S. market for the COVID-19 vaccine in the future could be between $5.2 billion and $12.9 billion, depending on the price of injections and who is eligible for receive them, Moderna Inc.’s chief commercial officer said Thursday.

Arpa Garay, speaking at Moderna’s annual research and development event, said this range was based on price assumptions of $64 to $100 per shot.

The lower end of the estimate also assumes that only the high-risk population in the United States would be eligible for the boosters – some 82 million people. The high end is based on the fact that all 258 million American adults are eligible for injections, and assumes that half would get them.

US officials have said the government’s supply of vaccines and antiviral treatments will run out over the next year, meaning they expect vaccines to start being sold commercially in sometime in 2023.

Globally, Garay said the size of the high-risk population that would be eligible for injections is around 340 million people. (Reporting by Michael Erman editing by Bill Berkrot)

Leave a Comment